Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Genetics of Suicide Risk in Schizophrenia Patients: The Association Between the Complement Component C4 Gene and Suicidality
FY 2022-23
Summary
In Canada, schizophrenia affects nearly 1% of the population, with an estimated number of 1 in 100 Canadians aged 10 years or older living with diagnosed schizophrenia. Among schizophrenia patients, suicide is a major cause of death, with approximately 50% attempting suicide and 10% dying from suicide. Although genetic components play a large role in schizophrenia, the underlying genetic factors of suicide are not well understood in schizophrenia patients.
The immune system has been suggested to play a key role in suicidality across psychiatric disorders, including schizophrenia. Recently, a region in the human DNA (complement component C4), which is associated with immune processes, has been found to be related to schizophrenia risk. In addition, preliminary work has suggested that this stretch of DNA might also be associated with suicide risk, which makes this region a promising candidate for studying suicide risk in schizophrenia patients. The C4 gene has multiple versions, with every person having different versions of this DNA stretch. Studies have illustrated that these differences are associated with schizophrenia risk. Therefore, this project will examine the relationship between different C4 gene versions and suicide risk in schizophrenia patients.
Despite great efforts, suicide rates remain strikingly high among schizophrenia patients, which could have devastating emotional and medical costs for our society. The outcomes of this study have the potential to expand our knowledge of genetic factors of suicide risk in schizophrenia patients. Also, this study could improve clinical care by aiding in the identification and vigilance of individuals predisposed to high suicide risk, and ultimately encourage early prevention strategies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486639
Name
Ebrahimi Mahbod
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Genetics of Suicide Risk in Schizophrenia Patients: The Association Between the Complement Component C4 Gene and Suicidality
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Complement Component C4; Complement System; Genetics; Immune System; Mental Health; Molecular Biology; Psychiatric Disorder; Schizophrenia; Schizophrenia Patients; Suicide Risk
Abstract
In Canada, schizophrenia affects nearly 1% of the population, with an estimated number of 1 in 100 Canadians aged 10 years or older living with diagnosed schizophrenia. Among schizophrenia patients, suicide is a major cause of death, with approximately 50% attempting suicide and 10% dying from suicide. Although genetic components play a large role in schizophrenia, the underlying genetic factors of suicide are not well understood in schizophrenia patients.
The immune system has been suggested to play a key role in suicidality across psychiatric disorders, including schizophrenia. Recently, a region in the human DNA (complement component C4), which is associated with immune processes, has been found to be related to schizophrenia risk. In addition, preliminary work has suggested that this stretch of DNA might also be associated with suicide risk, which makes this region a promising candidate for studying suicide risk in schizophrenia patients. The C4 gene has multiple versions, with every person having different versions of this DNA stretch. Studies have illustrated that these differences are associated with schizophrenia risk. Therefore, this project will examine the relationship between different C4 gene versions and suicide risk in schizophrenia patients.
Despite great efforts, suicide rates remain strikingly high among schizophrenia patients, which could have devastating emotional and medical costs for our society. The outcomes of this study have the potential to expand our knowledge of genetic factors of suicide risk in schizophrenia patients. Also, this study could improve clinical care by aiding in the identification and vigilance of individuals predisposed to high suicide risk, and ultimately encourage early prevention strategies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ebrahimi, Mahbod
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~